SLM
LSB

Snow Lake Management’s LakeShore Biopharma LSB Stock Holding History

Snow Lake Management’s Portfolio LSB Stock Details LSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-35,715
Closed -$286K – 7
2023
Q3 		$286K Hold
35,715
– – 0.32% 6
2023
Q2 		$493K Sell
35,715
-145,479
-80% -$2.15M 0.4% 11
2023
Q1 		$2.9M Buy
+181,194
New +$9.18M 1.72% 6

Other funds holding LSB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $864M AUM 906.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
SCM
Superstring Capital Management New York $158M AUM 418.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAM
Pinpoint Asset Management Hong Kong $576M AUM 43.65% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Snow Lake Management's LSB Position: Q4 2023 in Review

Snow Lake Management sold out of LakeShore Biopharma (LSB) in Q4 2023, closing a stake of 35,715 shares — an estimated $286K sold.

Snow Lake Management first reported a position in LSB in Q1 2023 and held it in 3 quarters. The position peaked at $2.9M in Q1 2023. 10 funds tracked by Wall St. Rank hold LSB as of Q4 2023.

  • Snow Lake Management reported no remaining LakeShore Biopharma position as of Q4 2023 after selling out during the quarter.
  • Snow Lake Management sold 35,715 LakeShore Biopharma shares in Q4 2023, an estimated $286K.
  • Snow Lake Management first reported a position in LakeShore Biopharma in Q1 2023 and held it in 3 quarters.
  • Snow Lake Management's LakeShore Biopharma position peaked at $2.9M in Q1 2023.
  • 10 funds tracked by Wall St. Rank held LakeShore Biopharma as of Q4 2023.

Based on Snow Lake Management's 13F filing for Q4 2023, filed 14 Feb 2024.